An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for SAREPTA THERAPEUTICS Inc
| Ticker | SRPT |
| FIGI | BBG000BCJ161 |
| CUSIP | 803607100 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 460 / 6.6% |
| Percentage held by institutional investors | 100.0% |
About
Sarepta Therapeutics, Inc. (Nasdaq: SRPT) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs (see the Products section below). Wikipedia